WallStSmart
RZLT

Rezolute Inc

NASDAQ: RZLT · HEALTHCARE · BIOTECHNOLOGY

$4.12
-2.37% today

Updated 2026-10-29

Market cap
$369.48M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$1 – $11
Volume
1.6M

Rezolute Inc (RZLT) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201220132014201520162017201820192020202120222023202420252026
Total assets$1.07M$1.10M$7.40M$11.26M$10.90M$10.63M$2.50M$12.25M$10.96M$42.61M$152.42M$123.72M$132.74M$175.49M$112.85M
Cash & equivalents$25878.00$527.00$5.93M$5.28M$4.06M$4.49M$1.65M$11.57M$9.96M$41.05M$150.41M$16.04M$70.40M$94.11M$10.62M
Current assets$1.07M$815549.00$6.31M$6.12M$4.49M$4.93M$2.01M$12.14M$10.52M$41.99M$152.10M$104.91M$128.65M$171.15M$107.80M
Total liabilities$2.36M$5.27M$997921.00$2.21M$2.13M$2.10M$6.46M$10.50M$3.60M$16.51M$2.95M$7.55M$11.73M$13.36M$12.16M
Current liabilities$2.36M$5.27M$964040.00$1.71M$1.73M$1.77M$6.25M$8.38M$3.23M$1.97M$2.46M$5.20M$9.61M$11.91M$11.42M
Long-term debt———$23000.00—————$13.97M$407000.00————
Shareholder equity$-1.29M$-4.16M$6.41M$9.05M$8.77M$8.53M$-3.96M$1.75M$7.37M$26.10M$149.47M$116.17M$121.00M$162.13M$100.69M
Retained earnings$-1.29M$-8.02M$-17.75M$-29.11M$-44.04M$-64.32M$-94.18M$-126.90M$-147.24M$-168.14M$-209.20M$-260.99M$-329.44M$-403.86M$-481.44M
Accounts receivable$864000.00$350516.00—$450167.00—————————$700000.00$500000.00
Inventory—$223000.00$289600.00$67218.00———————————
Goodwill———————————————

Frequently asked questions

How much free cash flow does RZLT generate?

RZLT produced $-64.64M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is RZLT's balance sheet healthy?

RZLT holds $10.62M in cash and equivalents against — in long-term debt, on $100.69M of shareholder equity. That debt is best read against the cash flow the business throws off each year.